Serum Ratio of Free Triiodothyronine to Thyroid-Stimulating Hormone: A Novel Index for Distinguishing Graves' Disease From Autoimmune Thyroiditis

被引:3
作者
Wu, Zhiyong [1 ,2 ]
Zhu, Yu [1 ,2 ]
Zhang, Min [1 ,2 ]
Wang, Chen [1 ,2 ]
Zhou, Lingli [1 ,2 ]
Liu, Wei [1 ,2 ]
Yang, Wenjia [1 ,2 ]
Li, Meng [1 ,2 ]
Zhang, Simin [1 ,2 ]
Ren, Qian [1 ,2 ]
Han, Xueyao [1 ,2 ]
Ji, Linong [1 ,2 ]
机构
[1] Peking Univ, Diabet Ctr, Peoples Hosp, Dept Endocrinol, Beijing, Peoples R China
[2] Peking Univ, Diabet Ctr, Peoples Hosp, Dept Metab, Beijing, Peoples R China
关键词
Graves' disease; autoimmune thyroiditis; thyrotoxicosis; thyroid function test; differential diagnosis; DIFFERENTIAL-DIAGNOSIS; RECEPTOR ANTIBODIES; CLINICAL-FEATURES; AUTOMATED-ASSAY; HYPERTHYROIDISM; THYROTOXICOSIS; TSH; DESTRUCTION; IMMUNOASSAY; THYROXINE;
D O I
10.3389/fendo.2020.620407
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Graves' disease (GD) and autoimmune thyroiditis (AIT) are two major causes of thyrotoxicosis that require correct diagnosis to plan appropriate treatment. The objectives of this study were to evaluate the usefulness of thyroid-related parameters for distinguishing GD from AIT and identify a novel index for differential diagnosis of thyrotoxicosis. Design: This retrospective study was performed using electronic medical records in Peking University People's Hospital (Beijing, China). Methods: In total, 650 patients with GD and 155 patients with AIT from December 2015 to October 2019 were included in cohort 1. Furthermore, 133 patients with GD and 14 patients with AIT from December 2019 to August 2020 were included in cohort 2 for validation of the novel index identified in cohort 1. All patients were of Chinese ethnicity and were newly diagnosed with either GD or AIT. Thyroid-related clinical information was collected before intervention by reviewing the patients' electronic medical records. Receiver operating characteristic curve analysis was used to identify the optimal cutoff for distinguishing GD from AIT. Results: In cohort 1, thyroid-stimulating hormone (TSH) receptor antibody was identified as the best indicator for distinguishing GD from AIT. The area under the receiver operating characteristic curve was 0.99(95% confidence interval: 0.98-0.99, p<0.0001)and the optimal cutoff was 0.84 IU/l (98% sensitivity and 99% specificity). The free triiodothyronine (FT3)/TSH ratio (FT3/TSH) was the second -best for distinguishing GD from AIT, the area under the receiver operating characteristic curve of FT3/TSH was 0.86 (95% confidence interval: 0.84-0.88, p<0.0001); its optimal cutoff was 1.99 pmol/mIU (79% sensitivity and 80% specificity). Its effectiveness was confirmed in cohort 2 (81% sensitivity and 100% specificity). Conclusions: The FT3/TSH ratio is a new useful index for differential diagnosis of thyrotoxicosis, especially when combined with TRAb.
引用
收藏
页数:7
相关论文
共 43 条
[21]   Diagnosis and discrimination of autoimmune Graves' disease and Hashimoto's disease using thyroid-stimulating hormone receptor-containing recombinant proteoliposomes [J].
Fukushima, Hidetaka ;
Matsuo, Hideaki ;
Imamura, Koji ;
Morino, Kazuhiko ;
Okumura, Katsuzumi ;
Tsumoto, Kanta ;
Yoshimura, Tetsuro .
JOURNAL OF BIOSCIENCE AND BIOENGINEERING, 2009, 108 (06) :551-556
[22]   Presence of Thyroid-Stimulating Hormone Receptor Antibodies in a Patient with Subacute Thyroiditis followed by Hypothyroidism and Later Graves' Disease with Ophthalmopathy: A Case Report [J].
Hallengren, Bengt ;
Planck, Tereza ;
Asman, Peter ;
Lantz, Mikael .
EUROPEAN THYROID JOURNAL, 2015, 4 (03) :197-200
[23]   Effective methimazole dose for childhood Graves' disease and use of free triiodothyronine combined with concurrent thyroid-stimulating hormone level to identify mild hyperthyroidism and delayed pituitary recovery [J].
Slyper, AH ;
Wyatt, D ;
Boudreau, C .
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2005, 18 (06) :597-602
[24]   THE TIME TO THYROID-STIMULATING HORMONE RECOVERY DURING MEDICAL TREATMENT IN GRAVES' DISEASE AND AUTONOMOUS HYPERTHYROIDISM [J].
Martin, S. ;
Sirbu, A. ;
Albu, A. ;
Barbu, C. B. ;
Florea, S. ;
Boscaiu, V. ;
Fica, S. .
ACTA ENDOCRINOLOGICA-BUCHAREST, 2013, 9 (03) :405-418
[25]   Lack of association between thyroid-stimulating hormone receptor haplotypes and Graves' disease in a northern Chinese population [J].
Xu, L. -D. ;
Zhang, X. -L. ;
Sun, H. -M. ;
Liu, P. ;
Ji, G. -H. ;
Guan, R. -W. ;
Yu, Y. ;
Jin, Y. ;
Chen, F. ;
Fu, S. -B. .
TISSUE ANTIGENS, 2011, 77 (01) :2-2
[26]   Relationship between Serum Thyroid-stimulating Hormone Receptor Autoantibodies and Activity and Severity of Thyroid Eye Disease [J].
Lee, Je Sang ;
Lee, Si Hyung ;
Kim, Bo Yeon ;
Jang, Sun Young .
JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2021, 62 (11) :1459-1464
[27]   Immunization of mice with a newly identified thyroid-stimulating hormone receptor splice variant induces Graves'-like disease [J].
Endo, Toyoshi ;
Kobayashi, Teturo .
JOURNAL OF AUTOIMMUNITY, 2013, 43 :18-25
[28]   Distributions of serum thyroid-stimulating hormone in 2020 thyroid disease-free adults from areas with different iodine levels: a cross-sectional survey in China [J].
B. Ren ;
S. Wan ;
L. Liu ;
M. Qu ;
H. Wu ;
H. Shen .
Journal of Endocrinological Investigation, 2021, 44 :1001-1010
[29]   Thyroid-stimulating hormone-secreting pituitary adenoma presenting with recurrent hyperthyroidism in post-treated Graves’ disease: a case report [J].
Yoshikazu Ogawa ;
Teiji Tominaga .
Journal of Medical Case Reports, 7 (1)
[30]   Distributions of serum thyroid-stimulating hormone in 2020 thyroid disease-free adults from areas with different iodine levels: a cross-sectional survey in China [J].
Ren, B. ;
Wan, S. ;
Liu, L. ;
Qu, M. ;
Wu, H. ;
Shen, H. .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (05) :1001-1010